Filter
1038
Text search:
hazard
approach
Featured
120
298
Language
Document type
465
189
166
111
56
29
11
6
2
2
1
Countries / Regions
53
42
38
29
24
21
21
19
15
15
14
13
12
12
11
11
10
10
10
8
7
7
7
7
7
7
7
6
6
6
5
5
4
4
4
4
4
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
292
192
75
55
24
18
14
1
Toolboxes
115
78
70
70
50
47
43
39
37
33
31
27
25
24
23
18
17
16
14
7
6
5
3
2
2
1
1
Policy framework.
Document No. : FDA/SMC/SMD/GL-RAR/2013/01
5th revised edition.
This document provides a ranking of medically important antimicrobials for risk management of antimicrobial resistance due to non-human use. The current revision took place at the seventh meeting of the AGISAR held in Raleigh, United States of America in 2016.
Made under Section 5 (c) of the Tanzania Food, Drugs and Cosmetics Act, 2003 | Second Edition
IAEA Safety Standards for protecting people and the environment
In 2015, 5.9 million children under age five died (1). The major causes of child deaths globally are pneumonia, prematurity, intrapartum-related complications, neonatal sepsis, congenital anomalies, diarrhoea, injuries and malaria (2). Most of these diseases and conditions are at least partially cau
...
SIGN 143. A national clinical guideline
Published May 2015, Revised 2018
Руководство ВОЗ по политике и практике информирования о рисках при чрезвычайных ситуациях (ИРЧС)
The Zimbabwe National Pharmacovigilance Policy Handbook, 2nd Edition updates the November 2013 version to indicate the Zimbabwe National Pharmacovigilance (PV) Centre’s compliance with the WHO Pharmacovigilance Indicators Handbook 2015.
Guidelines for national programmes and other stakeholders
Annexes for webposting and CD-Rom distribution with the policy guidelines
Morbidity and Mortality Weekly Report
Recommendations and Reports: July 7, 2006 / Vol. 55 / No. RR-9
Trials (2017) 18:152, DOI 10.1186/s13063-017-1881-z
Eur Respir J. 2014 April ; 43(4): 1132–1141. doi:10.1183/09031936.00203613.
